Not cancer · Austria
Cystic fibrosis
How is it diagnosed today? All babies are checked for cystic fibrosis with the newborn blood spot test. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.1 open trial in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Medicines, physiotherapy and diet support. NHS
10 medicines are approved for this disease in Austria:
Show all 10
- Aztreonam (Cayston) – approved in 2009
- Colistimethate sodium (Colobreathe) – approved in 2012
- Deutivacaftor and tezacaftor and vanzacaftor (Alyftrek) – approved in 2025
- Ivacaftor (Kalydeco) – approved in 2012
- Ivacaftor and tezacaftor and elexacaftor (Kaftrio, Trikafta) – approved in 2020
- Levofloxacin (Quinsair) – approved in 2015
- Lumacaftor and ivacaftor (Orkambi) – approved in 2015
- Mannitol (Bronchitol) – approved in 2012
- Tezacaftor and ivacaftor (Symkevi, Symdeko) – approved in 2018
- Tobramycin (Vantobra, Tobi Podhaler, TOBI Podhaler) – approved in 2011
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (12)
- Acetylcysteine – approved for it in the US
- Alpha-tocopherol (Vitamine E Provepharm) – approved for it in France
- Ceftazidime (Fortum, Ceftazidime Arrow) – approved for it in France
- Ciprofloxacin (Ciflox, Ciprofloxacine Zentiva) – approved for it in France
- Colistimethate (Tadim) – approved for it in France
- Dornase alfa (Pulmozyme) – approved for it in the US, Switzerland, and France
- Meropenem (Meronem, Meropenem Panpharma) – approved for it in France
- Pancreatin (Eurobiol, Creon) – approved for it in France
- Phytomenadione (Vitamine K1 Cheplapharm, Phytonadione) – approved for it in the US and France
- Pancreas powder (Eurobiol) – approved for it in France
- Ursodeoxycholic acid (Cholurso, Delursan, Ursolvan) – approved for it in France
- Retinol palmitate (Vitamine A Provepharm) – approved for it in France
Being tested in people
1 open trial in Austria, 151 worldwide. See the trials
- ELX/TEZ/IVA (Phase 3)
- HSK31858, tablet (Phase 3)
- iLet Bionic Pancreas System (BP) (Phase 3)
- Intermittent Moxifloxacin + Standard Care (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 0 were in animals and 1 in the lab. See them
No proof it works
We checked 9 things people say help with this disease against the research. See how far each has been tested
No trial in people on record yet:
- Cannabis and cannabinoids (CBD, THC) (only single reports in people)
- High-dose vitamin C (only single reports in people)
- Ivermectin (animal studies only)
- Statins (animal studies only)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
0 open trials in Austria with these filters
We found no open trial in Austria with these filters.
Available abroad (20 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
How the body processes inhaled colistimethate in healthy adults and bronchiectasis patients
2025-524324-22-00 · EU Clinical Trials Register
Countries: Belgium, Poland
- Edegem, Belgium – SGS Belgium
- Bialystok, Poland – Centrum Medycyny Oddechowej Mroz sp. j.
- Jozefow, Poland – Biokinetica S.A.
Age 18 and over
Contact the trial teamA Study of RSS0343 Tablets in Healthy Participants and in Participants With Mild or Moderate Renal Impairment
NCT07940829 · ClinicalTrials.gov
Countries: China
- Zhengzhou, China – The First Affiliated Hospital of Zhengzhou University
Ages 18 to 65
Contact the trial teamStudy of how brensocatib and midazolam affect each other in the body
2026-526670-16-00 · EU Clinical Trials Register
Ages 18 to 64
Contact the trial teamHSK31858 tablets in people with kidney problems and in people with healthy kidneys
NCT07915011 · ClinicalTrials.gov
Ages 18 to 70
Contact the trial teamHSK31858 tablets in people with liver impairment and normal liver function
NCT07913009 · ClinicalTrials.gov
Ages 18 to 70
Contact the trial teamTesting VX-581 for safety in healthy adults and people with cystic fibrosis
NCT07283770 · ClinicalTrials.gov
Countries: United States
- Overland Park, United States – Altasciences - Kansas City
Ages 18 to 55
Contact the trial teamAchromoPhage, a mix of bacteria-killing viruses, for adults with cystic fibrosis and lung infection
NCT07275905 · ClinicalTrials.gov
Countries: United States
- Pittsburgh, United States – University of Pittsburgh
Age 18 and over
Contact the trial teamInhaled BMD003 mRNA treatment for cystic fibrosis in Chinese patients aged 12 and older
NCT07485543 · ClinicalTrials.gov
Countries: China
- Beijing, China – Peking Union Medical College Hospital
Age 12 and over
Contact the trial teamTests dorzagliatin for blood sugar problems in people with cystic fibrosis
NCT06995651 · ClinicalTrials.gov
Countries: United States
- Philadelphia, United States – University of Pennsylvania Center for Human Phenomic Science (CHPS)
- Philadelphia, United States – Hospital of University of Pennsylvania
Age 18 and over
Contact the trial teamHow rifampicin and clarithromycin change the way the body handles RSS0343 tablets
NCT07696091 · ClinicalTrials.gov
Countries: China
- Guangzhou, China – The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Ages 18 to 55
Contact the trial teamTests stem cell injection into the testis for male infertility
NCT02641769 · ClinicalTrials.gov
Countries: Jordan
- Amman, Jordan – Stem Cells of Arabia
Ages 21 to 50
Contact the trial teamTests inhaled KB407 for cystic fibrosis in adults
NCT05504837 · ClinicalTrials.gov
Countries: United States
- Boise, United States – St. Lukes CF Center of Idaho
- Gainesville, United States – University of Florida - Gainesville
- Hawthorne, United States – New York Medical College/ Boston Children's Health Physicians
Age 18 and over
Contact the trial teamXenon gas MRI scans to study lung function in people with lung disease
NCT04624490 · ClinicalTrials.gov
Countries: United States
- Kansas City, United States – University of Kansas Medical Center
Age 3 and over
Contact the trial teamTests Symdeko in people with cystic fibrosis and rarer gene changes
NCT03587961 · ClinicalTrials.gov
Countries: United States
- Birmingham, United States – University of Alabama at Birmingham
Age 6 and over
Contact the trial teamTests lung changes in cystic fibrosis when airway clearance is stopped and restarted
NCT06339593 · ClinicalTrials.gov
Countries: United States
- Cincinnati, United States – Cincinnati Children's Hospital
Ages 12 to 21
Contact the trial teamBacteriophage Therapy Plus Antibiotics for Antibiotic-Resistant Lung Infections in Adults With Cystic Fibrosis
NCT07280598 · ClinicalTrials.gov
Age 18 and over
Contact the trial teamTests gallium nitrate infusions in adults with cystic fibrosis and NTM infection
NCT04294043 · ClinicalTrials.gov
Countries: United States
- Baltimore, United States – Johns Hopkins University
- Birmingham, United States – University of Alabama at Birmingham
- Burlington, United States – University of Vermont Medical Center
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests inhaled amphotericin B doses in healthy people and people with cystic fibrosis
NCT05802264 · ClinicalTrials.gov
Countries: Australia, New Zealand
- Brisbane, Australia – The Prince Charles Hospital
- Canberra, Australia – Canberra Hospital
- Clayton, Australia – Monash Medical Centre
Age 16 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests SP-101 inhaled through a nebulizer in adults with cystic fibrosis
NCT06526923 · ClinicalTrials.gov
Countries: United States
- Boston, United States – Boston Children's Hospital, Brigham & Women's Hospital
- Kansas City, United States – University of Kansas Medical Center
- New York, United States – Columbia University
Ages 18 to 65
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTesting oxygen with antibiotics for chronic lung infection in people with cystic fibrosis
2024-513197-22-02 · EU Clinical Trials Register
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- ReviewGenetic Counseling When One Partner Carries a CF-Causing Variant and the Other Has the Intronic IVS8-5T Variant.J Genet Couns · 2026-12-01
- In peopleTelerehabilitation-Based Group and Individual Exercise in People With Cystic Fibrosis: A Randomized Controlled Study.Pediatr Pulmonol · 2026-11-01
- Improved nutritional status but frequently elevated serum vitamin A in children with cystic fibrosis following elexacaftor/tezacaftor/ivacaftor: a prospective single-centre study.Respir Med · 2026-11-16
- Long-term survival and clinical outcomes following Lung transplantation in people with cystic fibrosis in Belgium.Respir Med · 2026-11-16
- Multisystem Critical Illness in Cystic Fibrosis and Pregnancy: Recurrent Enterococcal Urosepsis From Indwelling Bilateral Nephrostomy Tubes.Cureus · 2026-10-16
Is it true?
Saw something on social media? Fact-check it now.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Oesterreichische Lungenunion
Patient organisation for lung and airway diseases with a lung cancer focus area: information, videos, events, doctor search, online self-help. LuCE member.
Phone: 01 / 330 42 86
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (4)
- Cystic Fibrosis Europe
Federation of national CF patient organisations: patient perspective in standards of care, member training and information, patient-driven research (PORG), EU advocacy.
- EURORDIS – Rare Diseases Europe
Alliance of over 1,000 rare disease patient organisations, with a list of rare disease helplines by country.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.